CDKN2A and neoplasm: Although the original tumor grading was not based on the CDKN2A status in our discovery cohort, CDKN2A was homozygously deleted and dramatically downregulated in four progressed grade 4 tumors (Fig. 3c and Additional file 2: Fig. S3b).